Your browser doesn't support javascript.
loading
Resting phase-administration of lemborexant ameliorates sleep and glucose tolerance in type 2 diabetic mice.
Tsuneki, Hiroshi; Sugiyama, Masanori; Sato, Kiyofumi; Ito, Hisakatsu; Nagai, Sanaka; Kon, Kanta; Wada, Tsutomu; Kobayashi, Nao; Okada, Takuya; Toyooka, Naoki; Kawasaki, Masashi; Ito, Toshihiro; Otsubo, Ryota; Okuzaki, Daisuke; Yasui, Teruhito; Sasaoka, Toshiyasu.
Afiliação
  • Tsuneki H; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan; Department of Integrative Pharmacology, University of Toyama, Toyama, 930-0194, Japan. Electronic address: htsuneki@pha.u-toyama.ac.jp.
  • Sugiyama M; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Sato K; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Ito H; Department of Anesthesiology, University of Toyama, Toyama, 930-0194, Japan.
  • Nagai S; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Kon K; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Wada T; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
  • Kobayashi N; Graduate School of Pharma-Medical Sciences, University of Toyama, Toyama, 930-0194, Japan.
  • Okada T; Graduate School of Pharma-Medical Sciences, University of Toyama, Toyama, 930-0194, Japan.
  • Toyooka N; Graduate School of Pharma-Medical Sciences, University of Toyama, Toyama, 930-0194, Japan.
  • Kawasaki M; Center for Liberal Arts and Sciences, Toyama Prefectural University, Imizu, Toyama, Japan.
  • Ito T; Laboratory of Proteome Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan.
  • Otsubo R; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition,
  • Okuzaki D; Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, 565-0871, Japan.
  • Yasui T; Laboratory of Infectious Diseases and Immunity, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan; Laboratory of Immunobiologics Evaluation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition,
  • Sasaoka T; Department of Clinical Pharmacology, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan. Electronic address: tsasaoka@pha.u-toyama.ac.jp.
Eur J Pharmacol ; 961: 176190, 2023 Dec 15.
Article em En | MEDLINE | ID: mdl-37952563
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article